Opioid detox for Deerfield Beach — fentanyl-era protocols, buprenorphine done right.

RECO Island's Delray Beach detox campus is 22 minutes north of Deerfield Beach — close enough to keep family involvement realistic, far enough for meaningful separation from active-use environments around The Cove and Pioneer Park. Small-census, physician-led opioid detox with COWS-guided buprenorphine induction, current fentanyl-era low-dose protocols where indicated, and direct in-house transition to residential treatment. No waitlists, no third-party handoffs, and every client leaves with intranasal naloxone and a defined maintenance medication plan — buprenorphine, Sublocade, methadone referral, or extended-release naltrexone.

Deerfield Beach sits 13 miles south of RECO Island’s Delray Beach campus along A1A — roughly 22 minutes northbound depending on Federal Highway traffic. For clients coming out of The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, or the corridor around Goldcoast Centre, that short drive creates meaningful physical separation from the dealers, drug spots, and daily cues tied to active opioid use without exiling anyone from family, employer, or the outpatient prescribers they will eventually transition back to. Our opioid detox program is physician-led, small-census, and built around current fentanyl-era addiction medicine — not the induction playbook that worked in 2015.

Opioid withdrawal in the fentanyl era

Fentanyl and its analogs — carfentanil, para-fluorofentanyl, and the nitazene compounds now cutting the South Florida supply — have materially changed the clinical picture of opioid withdrawal. Compared with heroin or prescription oxycodone, fentanyl is dramatically more potent, more lipophilic, and pharmacokinetically less predictable. The result is a withdrawal syndrome that can emerge on a compressed timeline, hit harder in its autonomic and pain-mediated symptoms, and behave inconsistently between patients — even between two clients with similar reported daily use histories.

The traditional buprenorphine induction playbook — wait 12 to 24 hours after last opioid use, confirm moderate withdrawal on the COWS, dose to comfort — is no longer sufficient for many patients. Long tissue-depot fentanyl reservoirs can produce precipitated withdrawal when buprenorphine is introduced on the classic timeline, even at COWS scores that historically indicated readiness. Low-dose induction protocols (also called micro-induction or the Bernese method) — starting at 0.5 mg buprenorphine and titrating over several days while a taper opioid or residual fentanyl clears — have become a standard alternative for fentanyl-exposed patients. RECO Island’s physicians select the induction approach based on the individual clinical picture, not a one-size dose card.

COWS-guided buprenorphine induction

The Clinical Opiate Withdrawal Scale scores eleven domains: resting pulse, sweating, restlessness, pupil size, bone and joint aches, rhinorrhea or lacrimation, GI upset, tremor, yawning, anxiety or irritability, and gooseflesh skin. Totals of 5-12 indicate mild withdrawal, 13-24 moderate, 25-36 moderately severe, and 37+ severe. Nursing rescore intervals are typically every two to four hours through the acute induction window.

Standard buprenorphine induction begins when a client’s COWS crosses roughly 11-13 — enough clinical withdrawal to reduce precipitated-withdrawal risk without leaving patients suffering longer than necessary. Initial dosing is 2-4 mg sublingual, reassessed at 60-90 minutes, with subsequent 2-4 mg doses titrated across the first day to a stable range usually landing at 8-16 mg daily. Fentanyl-exposed patients on low-dose induction follow a slower arc described above.

Autonomic and symptomatic comfort medications supplement the induction: clonidine 0.1-0.2 mg for sympathetic hyperactivity and diaphoresis, loperamide for diarrhea, ondansetron for nausea, cyclobenzaprine or methocarbamol for muscle cramping, hydroxyzine or trazodone for sleep. Bone pain and myalgia are treated with NSAIDs where renal function allows. Every dose adjustment is tied to a documented COWS score rather than a subjective read of how a patient looks in the hallway.

Buprenorphine, methadone, or naltrexone — the MAT decision

Every client leaves detox with a defined maintenance medication plan. There are three evidence-based options for post-detox pharmacotherapy in opioid use disorder, and the decision is made collaboratively during the residential stay rather than deferred to a rushed outpatient handoff.

Buprenorphine (Suboxone, Zubsolv, Sublocade) is a partial mu-agonist with a ceiling effect that substantially reduces overdose risk. It’s office-based, well-tolerated, and by far the most commonly continued medication after discharge. Monthly Sublocade injection is offered to clients concerned about daily adherence or diversion pressure at home. Methadone is a full mu-agonist dispensed only through federally licensed opioid treatment programs; it has the strongest retention data of the three but requires daily clinic dosing initially. For clients with very high tolerance histories, prior buprenorphine failure, or a preference for the OTP structure, methadone is the right answer and we coordinate the referral before discharge. Extended-release naltrexone (Vivitrol) is a monthly injectable opioid antagonist that requires a fully opioid-free 7-10 day window before the first injection to avoid precipitated withdrawal — meaning it’s initiated during the residential stay after detox is complete, not at the door on discharge day.

Naloxone education and the safety net

The 30 days after opioid detox carry the highest overdose mortality risk in a person’s entire trajectory with the disease. Tolerance drops sharply during even a short abstinence; a return-to-use dose calibrated to pre-detox tolerance can now be a lethal dose. This isn’t hypothetical — the CDC and multiple published treatment-outcome cohorts have documented the post-detox mortality spike repeatedly.

Every RECO Island opioid detox client leaves with intranasal naloxone (typically two 4 mg Narcan devices), a naloxone prescription for refills, and — critically — trained family members who know how to use it. Family naloxone training happens during residential family programming and covers overdose recognition, correct intranasal administration, calling 911, rescue breathing, and the post-reversal window where a second dose may be needed as naloxone wears off before the opioid does. Combined with continued MAT and warm-handoff outpatient engagement, naloxone distribution is one of the few interventions with a documented survival benefit in the post-discharge window.

What to expect in your first 24 hours

Intake begins with a physician H&P, nursing assessment, urine drug screen, medical labs, and a full ASAM Criteria evaluation across all six dimensions — acute intoxication and withdrawal potential, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse potential, and recovery environment. That evaluation drives the level of care determination and the initial treatment plan the physician team writes that day.

Co-occurring conditions are screened with validated instruments: PHQ-9 for depression, GAD-7 for anxiety, PCL-5 for PTSD, and ASRS for adult ADHD. Untreated psychiatric comorbidity is the single biggest predictor of post-discharge return to use in opioid use disorder, so sertraline, mirtazapine, low-dose quetiapine for sleep, or buspirone for anxiety are initiated when clinically indicated. Clients meet their primary therapist within 24-48 hours; evidence-based modalities used throughout the residential stay include CBT for craving and thought patterns, DBT skills for distress tolerance, MI for ambivalence, and EMDR for the trauma history that so often sits underneath the addiction.

Insurance and admissions from Deerfield Beach

RECO Island works with most major commercial plans held by Deerfield Beach residents and employers: Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and out-of-state BCBS plans. Our admissions team runs a full verification of benefits before you arrive — deductible balance, out-of-pocket maximum, prior authorization requirements for both medical detox and residential — and delivers a written cost estimate before you commit.

From Deerfield Beach, the trip is straightforward: I-95 north to the Atlantic Avenue exit, or A1A up the coast through Highland Beach and Gulf Stream if the interstate is heavy. Same-day admission is standard when a bed is available and benefits are verified; there are no waitlists for the detox unit and no third-party handoff between detox and residential treatment.

Serving residents of: The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, Goldcoast Centre.